[CHELATEXX + CHELATEXX VIT-C Protocol To Treat and Prevent Progressive Cognitive Decline]

Directions For Use (DFU)

1. Ingest TWO CHELATEXX capsules with every meal
2. Ingest ONE CHELATEXX VIT-C tablet with every meal
3. Use dietary means, such as leafy green salads, bran cereals, stool softeners (Dulcolax) or even OTC laxatives (MiraLax) to ensure at least one daily bowel movement to eliminate the ammonia laden activated charcoal from your body. NOTE: Activated charcoal will blacken stools.

CHELATEXX is already FDA approved under monograph, Indicated as an Absorbent and an Antidote  drugs.com/monograph/charcoal-activated.html

CHELATEXX is not yet FDA approved for Progressive Cognitive Decline or Alzheimer's Disease. This is the purpose of the planned Phase 2/3 Double Blind Placebo Controlled Clinical Trial of CHELATEXX to be funded by the NIH/NIA, to gain FDA approval for Treatment and Prevention of Progressive Cognitive Decline and Alzheimer's Disease. This therapy can be initiated by any person even as early as 50 YO, if they have concerns about cognition or mental decline.

CHELATEXX is 360 mg USP Activated Charcoal 1600 meters square absorptance per gram encapsulated in an enteric coated capsule for dissolution of the capsule and release of the Activated Charcoal in the very distal ileum, for delivery of the Activated Charcoal into the colon (large intestines) three hours after each meal. TWO CHELATEXX capsules are ingested with each meal for a total Activated Charcoal dosage of 720 mg per meal.

The Activated Charcoal absorbs the neurotoxic ammonia at its site of production, the colon, and prevents the absorption of neurotoxic ammonia into the systemic circulation. This prevents the postprandial neurotoxic assault to the brain, to prevent Progressive Cognitive Decline and Alzheimer's disease. 

CHELATEXX VIT-C Has two physiological OTC drug actions
1. CHELATEXX VIT-C ensures that there is adequate Vitamin C to prevent Vitamin C deficiency and potential Progressive Cognitive Decline/Azlheimer's disease from the deficiency.
2. CHELATEXX VIT-C acidifies the colon to prevent ammonia systemic absorption of the neurotoxic ammonia produced in the colon.

CHELATEXX VIT-C is 250 mg USP vitamin C and is FDA approved under monograph to prevent Vitamin C deficiency and scurvy.  drugs.com/monograph/ascorbic-acid.html

CHELATEXX VIT-C is not yet FDA approved for Progressive Cognitive Decline or Alzheimer's Disease. This will also be studied in the planned Phase 2/3 Double Blind Placebo Controlled Clinical Trial for Progressive Cognitive Decline and Alzheimer's Disease with CHELATEXX.